Status:
RECRUITING
Screening Contrast-enhanced Mammography
Lead Sponsor:
CHU de Quebec-Universite Laval
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The main objective of this study is to compare the diagnostic performance of two diagnostic methods, namely CESM and MRI, in the evaluation of a lesion suspicious of breast cancer in 300 Quebec women ...
Eligibility Criteria
Inclusion
- Female aged 18 and over
- At least one breast lesion with BIRADS classification 5
Exclusion
- Refusal to perform the biopsy or surgery
- Pregnant or possibly pregnant woman
- Usual contraindication to contrast product
- Significant kidney failure
- Allergy to contrast medium
- hyperthyroidism
- Usual contraindications to MRI
Key Trial Info
Start Date :
December 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05390229
Start Date
December 12 2018
End Date
December 1 2025
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St-Sacrement Hospital
Québec, Quebec, Canada, G1S4L8